Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates

• click to rate

  Posted by Two Blokes May 1 - Filed in Stock - 0 views
  
  Agios Pharmaceuticals (AGIO) came out with a quarterly loss of $1.55 per share versus the Zacks Consensus Estimate of a loss of $1.80. This compares to loss of $1.45 per share a year ago.